Case Study: AstraZeneca achieves 15% managed travel spend savings with BCD Travel

AstraZeneca’s global consolidation drives data insights, savings and traveler satisfaction

AstraZeneca, the global biopharmaceutical company, wanted centralized visibility into and management of its worldwide travel program. With multiple travel management companies and siloed traveler data across more than 70 countries, the company lacked a timely, unified view of spend, making it harder to control costs, ensure duty of care, and improve the traveler experience. AstraZeneca partnered with BCD Travel, using platforms including DecisionSource®, TripSource®, and SolutionSource®.

BCD Travel led a global consolidation and implementation across 70 countries in just seven months, supported by traveler engagement, policy enforcement, and improved data analytics. The result was a 15% savings on managed travel spend in one year, 95% visibility into managed travel data, 100% visibility into BCD-booked trips, and 86% traveler satisfaction, along with higher policy compliance and better supplier leverage.

AstraZeneca

Kerrie Henshaw-Cox

Travel Program Leader